Background: Cyclophosphamide (CP) can induce severe hepatotoxicity in certain patients by generating oxidative molecules and increasing reactive oxygen species (ROS). There are limited reports on the antioxidant and anti-inflammatory properties of Sildenafil. Objectives: This study aimed to evaluate the effect of Sildenafil on CP-induced hepatotoxicity. Methods: Animals were randomly divided into five groups (n = 6): Group I (control) received water distillate by gavage. Group II received CP (200 mg/kg) intraperitoneally to induce hepatotoxicity. Group III was orally administered Sildenafil (75 mg/kg) along with CP (200 mg/kg), while Group IV received vitamin E (500 mg/kg) and CP (200 mg/kg). Group V was administered 75 mg/kg of Sildenafil, 200 mg/kg of CP, and 500 mg/kg of vitamin E. At the end of the experiment, blood samples were collected from the animals' hearts to measure serum levels of liver enzymes, including aspartate transaminase (AST) and alanine aminotransferase (ALT), as well as oxidative stress markers malondialdehyde (MDA), nitric oxide (NO), and ferric reducing antioxidant power (FRAP). Liver tissue was also collected for assessment of antioxidant enzyme activity, including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx), along with histological examination. Results: The CP-treated group exhibited significant increases in AST, ALT, MDA, and NO levels, while CAT, SOD, GPx, and FRAP levels were markedly lower in the CP group compared to the saline group (P ≤ 0.01). Administration of sildenafil, alone and in combination with vitamin E, significantly reduced levels of AST, ALT, MDA, and NO. Meanwhile, antioxidant enzyme activity was markedly enhanced following sildenafil and vitamin E intake (P ≤ 0.01). Additionally, histological analysis confirmed Sildenafil's hepatoprotective properties. Conclusions: This study demonstrated that Sildenafil, both alone and in combination with vitamin E, was effective in reducing CP-induced liver toxicity through antioxidant mechanisms. Therefore, these findings suggest that Sildenafil, especially when combined with vitamin E, may serve as a complementary therapy to mitigate the hepatotoxic effects of CP.